Dow AgroSciences Awarded Costs of $5.3 Million Based on Bayer's Inequitable Conduct
INDIANAPOLIS--(BUSINESS WIRE)-- In a ruling on September 28, 2012 in the U.S. District Court, Middle District of North Carolina, two affiliates of Dow AgroSciences (NYS: DOW) received a $5.3 million award against Bayer Bioscience in a lawsuit over Bayer's Bacillus thuringiensis biotechnology patents that were ultimately found in multiple legal proceedings to be unenforceable due to inequitable conduct.
Originally filed in 1995 by Plant Genetic Systems (PGS) - a subsidiary of Bayer Bioscience - the lawsuit claimed that insect resistant corn products from Mycogen Plant Sciences and Agrigenetics - now affiliates of Dow AgroSciences - had violated two PGS patents. Friday's $5.3 million award reimburses attorneys' fees and costs incurred by the Dow AgroSciences affiliates in defending against Bayer's litigation.
"We are pleased with the ruling, which supports Dow AgroSciences and its Affiliates providing important insect protection products to U.S. farmers," said William Wales, Vice President and General Counsel for Dow AgroSciences.
About Dow AgroSciences
Dow AgroSciences, based in Indianapolis, Indiana, USA, develops leading-edge crop protection and plant biotechnology solutions to meet the challenges of the growing world. Dow AgroSciences is a wholly owned subsidiary of The Dow Chemical Company and had annual global sales of $5.7 billion in 2011. Learn more at www.dowagro.com. Follow Dow AgroSciences on Facebook and YouTube or subscribe to our News Release RSS Feed.
Garry Hamlin, 317-337-4799
KEYWORDS: United States North America Indiana North Carolina
The article Dow AgroSciences Awarded Costs of $5.3 Million Based on Bayer's Inequitable Conduct originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.